Theranos collapse (2018)
Theranos claimed its machines could run hundreds of tests from a single drop of blood. Investigations found the technology did not work as promised. Founder Elizabeth Holmes was later convicted of fraud.
The company dissolved in 2018 and investors lost roughly $700 million.
It made investors and regulators far more skeptical of health startups that promise breakthrough diagnostics without published evidence.
Neko sells consumer diagnostics on a bold promise too. The Theranos memory raises the bar for proof that its scans actually improve health outcomes.
